These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24954667)
1. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. Liu Z; Tu K; Liu Q FEBS Lett; 2014 Aug; 588(17):3089-97. PubMed ID: 24954667 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer. Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953 [TBL] [Abstract][Full Text] [Related]
5. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y; Wang J; Han J; Luo D; Sun Z Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
9. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
10. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
11. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G; Lin Y; Zhang H; Wu D Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123 [TBL] [Abstract][Full Text] [Related]
12. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis. Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914 [TBL] [Abstract][Full Text] [Related]
14. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208 [TBL] [Abstract][Full Text] [Related]
15. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN. Zhang D; Zhou P; Wang W; Wang X; Li J; Sun X; Zhang L Oncol Rep; 2016 Jan; 35(1):366-74. PubMed ID: 26499912 [TBL] [Abstract][Full Text] [Related]
17. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4. Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
19. miR-501 acts as an independent prognostic factor that promotes the epithelial-mesenchymal transition through targeting JDP2 in hepatocellular carcinoma. Yu W; Deng W; Zhao Q; Zhuang H; Zhang C; Jian Z Hum Cell; 2019 Jul; 32(3):343-351. PubMed ID: 30877624 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]